- Published on
Medicine – Tumours of the Renal Tract
Tumours of the renal tract include benign renal tumours, renal cell carcinoma, Wilms tumour, and urothelial carcinoma. They differ considerably in their age of presentation, tissue of origin, risk factors, clinical manifestations, and associated syndromes.
An important distinction is between renal parenchymal tumours, such as renal cell carcinoma, and urothelial tumours, which arise from the lining of the renal pelvis, ureter, or bladder.
1. Benign Renal Tumours
Several benign tumours can arise within the kidney.
Important examples include:
Renal adenoma.
Angiomyolipoma.
Reninoma, or juxtaglomerular cell tumour.
Many benign renal masses are discovered incidentally during imaging performed for another reason.
2. Renal Adenoma
A renal adenoma is a small benign epithelial tumour of the kidney.
These lesions are often:
Asymptomatic.
Small.
Incidentally discovered.
Some renal adenomas can be difficult to distinguish histologically and radiologically from small malignant renal epithelial tumours.
3. Angiomyolipoma
The classic renal tumour traditionally described as a hamartomatous lesion is:
Angiomyolipoma.
It contains varying amounts of:
Blood vessels.
Smooth muscle.
Adipose tissue.
4. Angiomyolipoma and Tuberous Sclerosis
Renal angiomyolipomas have an important association with:
Tuberous sclerosis complex.
In tuberous sclerosis, they are more likely to be:
Multiple.
Bilateral.
Larger.
Larger lesions have an increased risk of spontaneous haemorrhage.
5. Juxtaglomerular Cell Tumour
A rare renin-producing renal tumour is the:
Juxtaglomerular cell tumour.
It is also called:
Reninoma.
This tumour secretes excessive:
Renin.
6. Reninoma and Hypertension
Excessive renin activates the:
Renin–angiotensin–aldosterone system.
This produces:
↑ Renin → ↑ angiotensin II → ↑ aldosterone.
The patient may therefore develop:
Hypertension.
Hypokalaemia.
Metabolic alkalosis.
7. Important Correction – Reninoma Does Not Cause Primary Conn Syndrome
The original note states that a renin-secreting tumour:
“Leads to Conn syndrome.”
This is not strictly correct.
Conn syndrome refers to primary hyperaldosteronism, in which aldosterone is produced autonomously, usually by the adrenal gland, and renin is suppressed.
In a reninoma:
Renin is high → aldosterone becomes high secondarily.
Therefore, the correct term is:
Secondary hyperaldosteronism.
8. Reninoma versus Conn Syndrome
Reninoma:
Renin ↑.
Aldosterone ↑.
Secondary hyperaldosteronism.
Conn syndrome:
Renin ↓.
Aldosterone ↑.
Primary hyperaldosteronism.
This distinction is clinically important.
9. Renal Cell Carcinoma
Renal cell carcinoma (RCC) is the most important primary malignant tumour arising from the renal parenchyma in adults.
It originates from:
Renal tubular epithelial cells.
Several histological subtypes exist.
10. Clear Cell Renal Cell Carcinoma
The most common subtype is:
Clear cell RCC.
It commonly arises from:
Proximal tubular epithelial cells.
Alterations involving the:
VHL tumour-suppressor pathway
are particularly important in clear cell RCC.
11. Von Hippel–Lindau Disease
Inherited von Hippel–Lindau disease markedly increases the risk of:
Clear cell RCC.
Other manifestations can include:
Retinal haemangioblastomas.
CNS haemangioblastomas.
Phaeochromocytomas in some patients.
Pancreatic lesions.
RCC may be bilateral or multifocal in hereditary disease.
12. Risk Factors for Renal Cell Carcinoma
Important established risk factors include:
Cigarette smoking.
Obesity.
Hypertension.
Chronic kidney disease.
Acquired cystic kidney disease, particularly in long-term dialysis.
Certain inherited syndromes, especially VHL disease.
Some occupational and chemical exposures have also been investigated.
13. Smoking
Smoking is an important modifiable risk factor for RCC.
Risk generally increases with greater cumulative exposure.
Smoking cessation reduces long-term risk.
14. Hypertension
Hypertension is independently associated with an increased risk of RCC.
It is important to distinguish this from hypertension occurring as a:
Manifestation of an existing RCC
through mechanisms such as renin secretion.
Thus hypertension may be both a background risk association and, less commonly, part of the tumour’s clinical presentation.
15. Chronic Kidney Disease and Transplantation
Patients with advanced chronic kidney disease, particularly those with:
Long-term dialysis and acquired cystic kidney disease,
have an increased risk of RCC.
Renal transplant recipients also have an increased overall risk of malignancy because of immunosuppression, and native-kidney RCC is an important consideration in this population.
16. Analgesic Exposure
Older teaching often lists:
Analgesic abuse
as a risk factor for renal tract malignancy.
A particularly strong classical association is between analgesic nephropathy, especially historical phenacetin-containing analgesics, and:
Upper urinary tract urothelial carcinoma.
Its relationship with RCC is less central than the major established RCC risks such as smoking, obesity, hypertension, and acquired cystic kidney disease.
17. Solvents and Heavy Metals
Some occupational exposures have been investigated as potential RCC risks.
However, the broad statement:
“Solvents or heavy metals cause RCC”
is too general.
For examination purposes, the most reliable major risk factors to prioritise are:
Smoking + obesity + hypertension + chronic renal disease/acquired cystic disease + hereditary syndromes.
18. Clinical Presentation of RCC
Renal cell carcinoma can remain asymptomatic for a long time.
Many cases are now discovered:
Incidentally on abdominal imaging.
When symptomatic, possible features include:
Haematuria.
Loin or flank pain.
Abdominal or flank mass.
Fever.
Weight loss.
Anaemia or polycythaemia.
Hypertension.
Paraneoplastic syndromes.
19. Classical Triad of RCC
The classical triad is:
Haematuria.
Flank pain.
Palpable abdominal mass.
However, the complete triad is uncommon and usually suggests relatively advanced disease.
Therefore, absence of the triad does not exclude RCC.
20. Haematuria
Haematuria is an important presenting feature.
It may be:
Visible haematuria
or
Microscopic haematuria.
Unexplained visible haematuria requires appropriate investigation for urinary tract malignancy.
21. Loin Pain
RCC may cause:
Persistent flank or loin discomfort.
Pain may result from:
Tumour expansion.
Local invasion.
Bleeding.
Obstruction.
22. Abdominal Mass
A sufficiently large renal tumour may become palpable as an:
Abdominal or flank mass.
This is generally a relatively late finding.
23. Pyrexia of Unknown Origin
RCC is classically associated with:
Unexplained fever.
Historically it is an important malignant cause of:
Pyrexia of unknown origin.
This reflects tumour-associated inflammatory cytokine production.
24. Paraneoplastic Syndromes
RCC is particularly notable for producing:
Paraneoplastic syndromes.
These may occasionally dominate the clinical presentation.
Important examples include:
Polycythaemia.
Hypercalcaemia.
Hypertension.
Fever.
Hepatic dysfunction without liver metastases.
25. Polycythaemia
Some RCCs produce excessive:
Erythropoietin.
This stimulates erythropoiesis and can cause:
Secondary polycythaemia.
Therefore:
RCC → ↑ EPO → ↑ red-cell production → polycythaemia.
However, anaemia is also common in patients with RCC, so polycythaemia is a classic but relatively uncommon manifestation.
26. Hypercalcaemia
RCC can cause:
Hypercalcaemia.
This may occur through tumour-mediated humoral mechanisms or metastatic bone disease.
It is another important paraneoplastic association.
27. Hypertension
RCC may occasionally produce hypertension through increased:
Renin activity.
Other mechanisms, including renal vascular compression, may contribute.
Therefore:
RCC → renin-related mechanisms → hypertension.
28. Stauffer Syndrome
RCC can cause abnormal liver function despite the absence of hepatic metastases.
This is called:
Stauffer syndrome.
It is a paraneoplastic hepatic dysfunction associated classically with RCC.
29. Renal Vein Invasion
RCC has a characteristic tendency to invade veins.
The tumour may extend into the:
Renal vein.
From there, it can extend into the:
Inferior vena cava.
In advanced cases, tumour thrombus may extend superiorly within the IVC.
30. Left-Sided Varicocele
The:
Left testicular vein
drains into the:
Left renal vein.
Therefore, obstruction of the left renal vein by a renal tumour may impair testicular venous drainage.
This can produce a:
Left-sided varicocele.
31. Suspicious Varicocele
A new:
Left-sided varicocele
particularly in an older adult, especially if it does not decompress when supine, should raise concern for obstruction of venous drainage, including a possible renal or retroperitoneal mass.
A new isolated right-sided varicocele may also warrant investigation for retroperitoneal pathology.
32. Metastatic Spread of RCC
RCC can spread:
Directly into surrounding structures.
Through the renal vein and IVC.
Through lymphatics.
Haematogenously.
Common metastatic sites include:
Lungs.
Bones.
Liver.
Brain.
33. Diagnosis of RCC
Renal masses are commonly evaluated using:
Ultrasound.
Contrast-enhanced CT.
MRI in selected circumstances.
CT of the abdomen and pelvis is particularly important for assessing:
Tumour size.
Local invasion.
Renal vein or IVC involvement.
Lymph nodes.
Metastatic disease.
34. Treatment of Localised RCC
Surgery is the major treatment for localised RCC.
Depending on tumour size and location, options include:
Partial nephrectomy
or
Radical nephrectomy.
Nephron-sparing surgery is preferred when oncologically appropriate.
35. Wilms Tumour
Wilms tumour, or:
Nephroblastoma,
is an embryonal malignant renal tumour occurring predominantly in:
Children.
It arises from primitive nephrogenic tissue.
36. Presentation of Wilms Tumour
A typical presentation is:
Painless abdominal mass in a child.
Other possible features include:
Abdominal pain.
Haematuria.
Hypertension.
Fever.
The abdominal mass may be discovered by a parent during bathing or dressing.
37. Wilms Tumour Associations
Wilms tumour has important associations with several congenital syndromes.
These include:
WAGR syndrome.
Denys–Drash syndrome.
Beckwith–Wiedemann syndrome.
38. WAGR Syndrome
WAGR refers to:
W – Wilms tumour.
A – Aniridia.
G – Genitourinary abnormalities.
R – Developmental delay, historically termed intellectual retardation.
This syndrome is associated with abnormalities involving chromosome 11p.
39. Urothelial Tumours
Tumours arising from the lining of the urinary tract are called:
Urothelial carcinomas.
The older term is:
Transitional cell carcinoma.
Modern terminology generally prefers:
Urothelial carcinoma.
40. Sites of Urothelial Carcinoma
Urothelium lines the:
Renal pelvis.
Ureters.
Urinary bladder.
Parts of the urethra.
Therefore, urothelial carcinoma can occur at multiple sites along the urinary tract.
The:
Bladder
is by far the most common site.
41. Presentation of Urothelial Carcinoma
The classic presentation is:
Painless visible haematuria.
This is one of the most important clinical warning signs.
Other possible manifestations include:
Urinary frequency.
Urgency.
Dysuria.
Flank pain or obstruction if the upper tract is involved.
42. Urinary Tract Obstruction
A urothelial tumour can obstruct:
A ureter.
The ureteric orifice.
The bladder outlet in selected cases.
Upper tract obstruction may cause:
Hydronephrosis.
Flank pain.
Renal impairment.
43. Multifocality
Urothelial carcinoma may be:
Multifocal.
This reflects the exposure of a large area of urothelium to carcinogenic influences and the biological tendency of urothelial malignancy to recur at different sites.
Therefore, long-term surveillance is often important.
44. Smoking and Urothelial Carcinoma
The most important risk factor is:
Cigarette smoking.
Tobacco carcinogens are absorbed, metabolised, and eventually excreted in urine, exposing the urothelium.
Smoking is therefore a major risk factor for:
Bladder urothelial carcinoma
and
Upper urinary tract urothelial carcinoma.
45. Occupational Exposure
Certain occupational aromatic amines are associated with urothelial carcinoma.
Historical high-risk industries include:
Dye manufacture.
Rubber industry.
Leather and chemical industries.
The classical association with:
Aniline dye exposure
reflects exposure to carcinogenic aromatic amines.
46. Analgesic Nephropathy
Historical heavy exposure to certain analgesics, particularly:
Phenacetin-containing preparations,
was associated with:
Analgesic nephropathy
and an increased risk of:
Upper urinary tract urothelial carcinoma.
This is an important classical examination association.
47. Renal Calculi and Chronic Irritation
Chronic urinary tract irritation and inflammation can predispose to malignant transformation.
However, renal calculi are particularly associated with chronic irritation and an increased risk of:
Squamous cell carcinoma
rather than being one of the strongest classic risk factors for ordinary urothelial carcinoma.
This distinction is useful.
48. Schistosomiasis
Chronic infection with:
Schistosoma haematobium
is strongly associated with:
Squamous cell carcinoma of the bladder.
Therefore, the original association between schistosomiasis and “transitional cell tumours” needs correction.
The high-yield association is:
Schistosoma haematobium → chronic bladder inflammation → squamous cell carcinoma.
49. Squamous Cell Carcinoma of the Bladder
Squamous cell carcinoma is much less common than urothelial carcinoma in many regions.
It is associated with chronic irritation, particularly:
Schistosomiasis.
Long-standing bladder stones.
Chronic catheterisation or chronic inflammation.
50. Renal Cell Carcinoma – Note Form
Origin:
Renal tubular epithelium.
Clear cell RCC is the most common subtype.
Major risk factors:
Smoking.
Obesity.
Hypertension.
Chronic kidney disease/acquired cystic kidney disease.
Hereditary syndromes such as VHL.
Clinical features:
Haematuria.
Loin or flank pain.
Abdominal mass.
Fever or PUO.
Weight loss.
Venous invasion:
Renal vein → IVC.
May produce a left-sided varicocele through impaired left gonadal venous drainage.
Paraneoplastic features:
Erythropoietin → polycythaemia.
Renin-related mechanisms → hypertension.
Hypercalcaemia.
Stauffer syndrome.
51. Wilms Tumour – Note Form
Alternative name:
Nephroblastoma.
Age:
Predominantly children.
Origin:
Embryonal nephrogenic tissue.
Typical presentation:
Painless abdominal mass.
Associations:
WAGR.
Denys–Drash.
Beckwith–Wiedemann.
52. Urothelial Carcinoma – Note Form
Older name:
Transitional cell carcinoma.
Origin:
Urothelium.
Sites:
Renal pelvis.
Ureter.
Bladder.
Urethra.
Typical presentation:
Painless visible haematuria.
May cause urinary obstruction.
Behaviour:
Can be multifocal and recurrent.
Major risk factors:
Smoking.
Occupational aromatic amine exposure.
Historical phenacetin/analgesic nephropathy.
53. Important Corrections to the Original Notes
Renin-secreting juxtaglomerular tumour does NOT cause Conn syndrome.
It causes:
Secondary hyperaldosteronism with high renin and high aldosterone.
Conn syndrome is:
Primary hyperaldosteronism with low renin.
The most useful established RCC risk factors to prioritise are:
Smoking + obesity + hypertension + chronic renal disease/acquired cystic kidney disease + hereditary syndromes.
The modern term for:
Transitional cell carcinoma
is:
Urothelial carcinoma.
Schistosoma haematobium is classically associated with:
Squamous cell carcinoma of the bladder, not specifically ordinary urothelial carcinoma.
Likewise, chronic bladder stones and long-standing irritation are particularly important risk factors for:
Squamous cell carcinoma.
Key Clinical Pattern
For renal cell carcinoma, remember:
HAEMATURIA + FLANK PAIN + ABDOMINAL MASS
but the complete triad is uncommon.
Also remember:
RCC LOVES VEINS → RENAL VEIN → IVC.
LEFT RENAL VEIN OBSTRUCTION → LEFT VARICOCELE.
RCC → EPO → POLYCYTHAEMIA.
RCC → RENIN → HYPERTENSION.
RCC → HYPERCALCAEMIA.
For Wilms tumour, think:
CHILD + PAINLESS ABDOMINAL MASS.
For urothelial carcinoma, think:
PAINLESS HAEMATURIA + SMOKING + AROMATIC AMINE EXPOSURE + MULTIFOCALITY.
And keep the important distinction:
SCHISTOSOMA HAEMATOBIUM → SQUAMOUS CELL CARCINOMA OF BLADDER.